Clofibric acid
CAS No. 882-09-7
Clofibric acid( NSC 1149 )
Catalog No. M16397 CAS No. 882-09-7
Clofibric acid is a PPARα agonist and hypolipidemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClofibric acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionClofibric acid is a PPARα agonist and hypolipidemic agent.
-
DescriptionClofibric acid is a PPARα agonist and hypolipidemic agent.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 1149
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number882-09-7
-
Formula Weight214.65
-
Molecular FormulaC10H11ClO3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 43 mg/mL (200.32 mM); DMSO: 43 mg/mL (200.32 mM)
-
SMILESCC(C)(OC1=CC=C(Cl)C=C1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Richert L, et al. Toxicol Appl Pharmacol, 2003, 191(2), 130-146.
molnova catalog
related products
-
SR 16832
SR 16832 is a dual-site PPARγ inhibitor. It also inhibits the binding of endogenous ligands and transcriptional activity of PPARγ, more effectively than the orthosteric covalent antagonist GW 9662 and T 0070907.
-
Saroglitazar magnesi...
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively.
-
MCC 555
MCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) is an activating ligand of PPARγ with EC50 of 8 uM.
Cart
sales@molnova.com